Modulation of inflammatory responses by Factor XI

Details for Australian Patent Application No. 2010236286 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Monia, Brett P.; Crosby, Jeffrey R.; Macleod, Robert A.; Freier, Susan M.

Agent FB Rice

Pub. Number AU-A-2010236286

PCT Pub. Number WO2010/121074

Priority 61/169,701 15.04.09 US; PCT/ US2009/060922 12.11.09 US

Filing date 15 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

10 November 2011 Amendment Made

  The nature of the amendment is: Amend the priority details to read 61/169,701 15 Apr 2009 US and PCT/US2009/060922 06 May 2009 US 2010236404 Research Triangle Institute The nature of the amendment is as shown in the statement(s) filed 14 Oct 2011

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/121074 Priority application(s): WO2010/121074

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236288-Vascular implant and delivery system

2010236279-High-speed cooking oven with optimized cooking efficiency